|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00763724 |
|
Date of registration:
|
30/09/2008 |
|
Primary sponsor: |
|
|
Public title:
|
Antidepressant Drug Exposure and Risk of Suicide Attempt Resulting in Medical Intervention in US Adults
|
|
Scientific title:
|
A Propensity-Matched Retrospective Cohort Study of Antidepressant Drug Exposure and Risk of Suicide Attempt in Adults From a Large U.S. Managed Care Population |
|
Date of first enrolment:
|
June 2008 |
|
Target sample size:
|
254432 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00763724 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Retrospective
|
|
|
Contacts
|
|
Name:
|
Call 1-877-CTLILLY (1-877-285-4559) or 317-615-4559 Mon-Fri 9am - 5pm Eastern time (UTC/GMT - 5 hours, EST) |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Eli Lilly and Company |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Age 18 years or older at index date
- Have at least 6 months of continuous enrollment data prior to index date.
- Have complete medical, facility, and pharmacy records (the latter of which will
include complete quantity and days supplied information).
Exclusion Criteria:
- None
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Depression
|
|
Suicide
|
|
Primary Outcome(s)
|
|
Incidence of suicide attempt resulting in medical encounter or hospitalization.
[Time Frame: Endpoint]
|
|
Secondary Outcome(s)
|
|
Relative risk of suicide attempt resulting in medical encounters or hospitalization
[Time Frame: Endpoint]
|
|
Secondary ID(s)
|
|
12016
|
|
F1J-MC-B027
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|